Vivoryon Therapeutics NV
(STU:05Y)
€
8.13
0 (0%)
Market Cap: 51.09 Mil
Enterprise Value: 22.55 Mil
PE Ratio: 0
PB Ratio: 2.15
GF Score: 32/100 Vivoryon Therapeutics NV (STU:05Y) Transcripts
- Q1 2024 Vivoryon Therapeutics NV Earnings Call TranscriptMay 23, 2024€8.13Earnings
- Q4 2023 Vivoryon Therapeutics NV Earnings Call TranscriptApr 24, 2024€8.13Earnings
- Q3 2023 Vivoryon Therapeutics NV Earnings Call TranscriptDec 06, 2023€8.13Earnings
- Vivoryon Therapeutics NV at Virtual R&D Event with Key Opinion Leaders TranscriptOct 17, 2023
- Half Year 2023 Vivoryon Therapeutics NV Earnings Call TranscriptSep 07, 2023€8.13Earnings
- Q4 2022 Vivoryon Therapeutics NV Earnings Call TranscriptApr 19, 2023€8.13Earnings
- Vivoryon Therapeutics NV at Barclays Global Healthcare Conference TranscriptMar 16, 2023
- Q3 2022 Vivoryon Therapeutics NV Earnings Call TranscriptNov 22, 2022€8.13Earnings
- Q2 2022 Vivoryon Therapeutics NV Earnings Call TranscriptSep 30, 2022€8.13Earnings
- Vivoryon Therapeutics NV Corporate Call TranscriptAug 02, 2022
- Vivoryon Therapeutics NV Annual Shareholders Meeting TranscriptJun 22, 2022
- Q4 2021 Vivoryon Therapeutics NV Earnings Call TranscriptApr 28, 2022€8.13Earnings
- Q2 2021 Vivoryon Therapeutics NV Earnings Call TranscriptSep 21, 2021€8.13Earnings
- 1